Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-277766 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 22, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,500
Total Value
$300,125.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Common Stock | โ | Jun 22, 2026 | Exercise/Conversion | 2,500 | $21.05 | $52,625.00 | 52,695 | Direct | โ | View Details | |
Chief Business Officer | Common Stock | โ | Jun 22, 2026 | Sale | 2,500 | $99.00 | $247,500.00 | 50,195 | Direct | โ | View Details | |
Chief Business Officer | Stock Option (Right to Buy) | Derivative | Jun 22, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 95,000 | Direct | โ | View Details |